Intérêt de l'association ceftazidime et aztréonam dans les exacerbations de mucoviscidose à Pseudomonas aeruginosa multirésistant

In chronically P. aeruginosa colonised cystic fibrosis patients, ceftazidime and aztreonam combination (± tobramycin, ± ciprofloxacin) is well tolerated and efficient. This treatment suggests a clinical and functional benefit is possible, even in patients with severe disease.